Novo Nordisk logo
Back
  • Patients
    Patients
    Type 2 diabetes
    • Type 2 diabetes
    Type 1 diabetes
    • Type 1 diabetes
    Gestational diabetes
    • Gestational diabetes
    Diabetes pens and needles support
    • Diabetes pens and needles support
    Obesity
    • Obesity
    Haemophilia
    Growth disorders and growth hormone pens
    • Growth disorders and growth hormone pens
    Disease experience expert panel (DEEP)

    People living with a serious chronic disease are experts by experience. By sharing their experience, they help us improve the future of healthcare.

    Participating in our clinical trials

    More than 25,000 people participate in our clinical trials each year. They are one of the most important steps to finding new medicines.

  • Research & Development
    Research & Development
    Science & innovation
    • Science & innovation
    • Our scientific approach
    • Stem cell research
    • R&D facts & figures
    • Global R&D centres
    • Publications
    Our therapy areas
    • Our therapy areas
    • Type 1 diabetes
    • Type 2 diabetes
    • Obesity
    • Atherosclerosis
    • NASH
    • Haemophilia
    • Growth disorders
    Partner with us
    • Partner with us
    • Partnering opportunities
    • Events & meetings
    • Contact us
    Future science

    Look at our future science

    Pipeline

    Review our clinical pipeline

    Clinical trials

    What is a clinical trial and how to participate

    Bioethics
    • Bioethics
    • Animal ethics
    • Clinical trial ethics
    • Human biosample ethics
    • Stem cell ethics
    • Gene technology ethics
  • Sustainable business
    Sustainable business
    A sustainable company

    We believe that a healthy environment, society and economy are fundamental to long-term business success, and we will play our part, also on the long-term.

    Access and affordability in diabetes
    • Access and affordability in diabetes
    • Our access to insulin commitment
    • Medicines affordability in the US
    • Programmes and partnerships
    • World Diabetes Foundation
    • Novo Nordisk Haemophilia Foundation
    Zero environmental impact
    Preventing type 2 diabetes
    Transparency & reporting
    • Human rights
    • Integrated reporting
    • The Sustainable Development Goals
    • Principles, positions and policies
    Frequently asked questions

    Find answers to some of the more frequently asked questions on sustainability and responsible business practices.

  • Careers
    Careers
    Join us
    • Available Jobs
    • Email Job Agent
    • Working at Novo Nordisk
    • Employee Perspectives
    • Moving to Denmark
    • Meet Us - Event Calendar
    Professionals
    • Research & Development
    • Manufacturing
    • Corporate Functions
    • Finance, Legal and Procurement
    • IT
    Career programmes
    • PhD and PostDocs
    • Pharmaceutical Medicine Programme (PMP)
    Graduates, students and trainees
    • Graduates
    • Students
    • Trainees - Elev
  • About Novo Nordisk
    
  • Media
  • Products
  • Investors
  • Partnering
  • Contact us
Novo Nordisk Worldwide
Back Job Ad Display
  • Home
  • /Careers
  • /Working at Novo Nordisk
  • /Job Ad Display

 


Share on LinkedIn
Share on Facebook
Share on Twitter

  • Twitter icon
  • Facebook icon
  • YouTube icon
  • Linkedin icon
  • Instagram icon
  • Social media iconOverview

Who we are

Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.

Headquartered in Denmark, Novo Nordisk employs approximately 42,200 people in 80 countries, and markets its products in more than 170 countries. 

Novo Nordisk websites

  • US flag graphicNovo Nordisk in the USA
  • DK flag graphicNovo Nordisk in Denmark

Novo Nordisk Worldwide

Novo Nordisk Worldwide - global contact information

Addresses and global contacts

 

Important safety information about colour change for Fiasp® FlexTouch® and Fiasp® Penfill®

Read more about the issue
 

Shareholder Information

Share Info

Annual reporting

Annual Report 2018

Contact quick links

  • Contact customer services
    in your country
  • Report a side effect
  • Report product complaints
  • Report falsified products
  • Report a concern to the Compliance Hotline
  • Media contact
© 2019 Novo Nordisk A/S Disclaimer/Privacy Sitemap Contact us